Depression is difficult to detect in cancer patients, though its determination offers an opportunity to relieve patients' suffering in palliative care. Selective serotonin reuptake inhibitors (SSRIs) are the treatment of choice for mood disorders, but they show a highly variable response. The short allelic variants "s/s" and "s/l" of the 5-HTTLPR polymorphism in the promoter region of the serotonin transporter gene has been consistently associated with a poorer response to SSRIs. The aim of this study has therefore been to examine depression, anxiety and mental adaptation to cancer in terminally ill and depressed cancer patients, in relation to treatment with sertraline and to the 5-HTTLPR genetic polymorphism. Eleven consecutive depressed ...
Objective:Several studies have implicated the 5-HTTLPR polymorphism in treatment outcomes of selecti...
BACKGROUND: In major depressive disorder, selective serotonin reuptake inhibitors target the seroton...
The aim of this pilot study was to examine the relationship between clinical response, adverse effec...
The aim of this study was to examine the effects of the SSRI antidepressant drug citalopram on anxie...
The aim of this study was to examine the effects of the SSRI antidepressant drug citalopram on anxie...
Aims and background. In palliative care, few data are available on the diagnosis and treatment ofmoo...
Background: Mixed evidence in the general population and medically ill patients has suggested that h...
BACKGROUND: Mixed evidence in the general population and medically ill patients has suggested that h...
Abstract. Background: 5-HTTLPR genetic polymorphism of serotonin transporter (SERT) and stressful li...
Background. Difficulties in coping with cancer, and the accompanying anxious and depressive symptoms...
of psychiatry, university of bologna, bologna, italy SummARy – depression pharmacotherapy can be des...
The serotonin transporter (5-HTT) is a candidate locus for aetiological involvement in affective dis...
Antidepressants are used to treat several psychiatric disorders; however, a large proportion of pati...
The majority of antidepressant drugs act by increasing synaptic serotonin levels in the brain. Genet...
The serotonin transporter (5-HTT) is a candidate locus for aetiological involvement in affective dis...
Objective:Several studies have implicated the 5-HTTLPR polymorphism in treatment outcomes of selecti...
BACKGROUND: In major depressive disorder, selective serotonin reuptake inhibitors target the seroton...
The aim of this pilot study was to examine the relationship between clinical response, adverse effec...
The aim of this study was to examine the effects of the SSRI antidepressant drug citalopram on anxie...
The aim of this study was to examine the effects of the SSRI antidepressant drug citalopram on anxie...
Aims and background. In palliative care, few data are available on the diagnosis and treatment ofmoo...
Background: Mixed evidence in the general population and medically ill patients has suggested that h...
BACKGROUND: Mixed evidence in the general population and medically ill patients has suggested that h...
Abstract. Background: 5-HTTLPR genetic polymorphism of serotonin transporter (SERT) and stressful li...
Background. Difficulties in coping with cancer, and the accompanying anxious and depressive symptoms...
of psychiatry, university of bologna, bologna, italy SummARy – depression pharmacotherapy can be des...
The serotonin transporter (5-HTT) is a candidate locus for aetiological involvement in affective dis...
Antidepressants are used to treat several psychiatric disorders; however, a large proportion of pati...
The majority of antidepressant drugs act by increasing synaptic serotonin levels in the brain. Genet...
The serotonin transporter (5-HTT) is a candidate locus for aetiological involvement in affective dis...
Objective:Several studies have implicated the 5-HTTLPR polymorphism in treatment outcomes of selecti...
BACKGROUND: In major depressive disorder, selective serotonin reuptake inhibitors target the seroton...
The aim of this pilot study was to examine the relationship between clinical response, adverse effec...